Refine by
Therapy Development Articles & Analysis: This-Year
1 news found
Zetagen Therapeutics announces the MBC-003 ph2a preliminary results to be featured in an ASCO abstract for 2026.About Zetagen TherapeuticsFounded in 2015, Zetagen Therapeutics is a private, clinical-stage, biopharmaceutical company dedicated to developing breakthrough therapies via local administration for metastatic and primary cancers to bone and other organs. ...